Drug intelligence / Profile preview

chlorphenamine + dexamethasone

Development stage
Unknown
Lead developer
Can Tho University of Medicine and Pharmacy
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

**Chlorphenamine + dexamethasone** is a combination drug comprising a first-generation antihistamine (chlorphenamine, also known as chlorpheniramine) and a synthetic glucocorticoid corticosteroid (dexamethasone)[3][8][7]. Chlorphenamine acts as a competitive antagonist at the histamine H1 receptor, thereby reducing allergic symptoms such as itching, sneezing, and rash[3][6]. Dexamethasone binds to the glucocorticoid receptor, inhibiting inflammatory mediators and transcription factors (such as NF-κB and phospholipase A2), and modulating gene expression to produce anti-inflammatory and immunosuppressive effects[1][3][5]. The combination is used for anti-allergic and anti-inflammatory therapy in dermatology and allergy, and in veterinary medicine for symptomatic relief and recovery, particularly in allergy and joint/muscle inflammation[3][8]. The drugs provide synergistic effects, allowing reduced doses of corticosteroids and antihistamines, increasing clinical efficacy and potentially reducing adverse effects[5].

Brand names
Dexalergin
Other names
chlorpheniramine + dexamethasonechlorphenamine maleate + dexamethasonechlorpheniramine maleate + dexamethasone
02

Targets

HRH1 (Histamine H1 Receptor)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)PRSS1 (Trypsin family)GR (Glucocorticoid receptor)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on chlorphenamine + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorphenamine + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call